Literature DB >> 30582277

Anomalies of the genitourinary tract in children with 22q11.2 deletion syndrome.

Jason P Van Batavia1, Terrence B Crowley2, Evanette Burrows2, Elaine H Zackai2, Simone Sanna-Cherchi3, Donna M McDonald-McGinn2, Thomas F Kolon1.   

Abstract

The 22q11.2 deletion syndrome (22q11.2DS) involves multiple organ systems with variable phenotypic expression. Genitourinary tract abnormalities have been noted to be present in up to 30-40% of patients. At our institution, an internationally recognized, comprehensive, and multidisciplinary 22q11.2DS care center has been providing care to these children. We sought to report on the incidence of genitourinary tract anomalies in this large cohort and, therefore, retrospectively reviewed all patients who underwent a complete evaluation from 1992 to March 2017. We identified all children with any genital or urinary tract anomaly. For all children with a diagnosis of hydronephrosis, the underlying etiology was determined, when possible. Overall, 1,073 of 1,267 children with 22q11.2DS underwent renal evaluations at our institution. Hundered Sixty-Two (15.1%) children had structural abnormalities of their kidneys/urinary tracts. The majority of children with hydronephrosis (63%) had isolated upper tract dilation without any additional diagnoses. Boys were significantly more likely to be diagnosed with a genital abnormality than girls (7.7 vs. 0.5%, p < 0.001). Of the 649 boys in the entire cohort, 24 (3.7%) had cryptorchidism and 24 (3.7%) had hypospadias, which was noted to be mild in all except one boy. Overall, findings of hydronephrosis, unilateral renal agenesis, and multicystic dysplastic kidney occur at higher rates than expected in the general population. Given these findings, in addition to routine physical examination, we believe that all patients with 22q11.2DS warrant screening RBUS at time of diagnosis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  22q11.2 deletion syndrome; DiGeorge syndrome; genitourinary; pediatrics; renal; urology

Mesh:

Year:  2018        PMID: 30582277      PMCID: PMC6491205          DOI: 10.1002/ajmg.a.61020

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  21 in total

1.  Renal malformations in deletion 22q11.2 patients.

Authors:  Annegret Kujat; Marc D Schulz; Sibylle Strenge; Ursula G Froster
Journal:  Am J Med Genet A       Date:  2006-07-15       Impact factor: 2.802

Review 2.  What is the normal prevalence of vesicoureteral reflux?

Authors:  M A Sargent
Journal:  Pediatr Radiol       Date:  2000-09

3.  Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development.

Authors:  Meade Haller; Qianxing Mo; Akira Imamoto; Dolores J Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 4.  Increased incidence of renal anomalies in patients with chromosome 22q11 microdeletion.

Authors:  T L Stewart; M B Irons; J M Cowan; D W Bianchi
Journal:  Teratology       Date:  1999-01

Review 5.  Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes.

Authors:  Lisa J Kobrynski; Kathleen E Sullivan
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

6.  DiGeorge syndrome: part of CATCH 22.

Authors:  D I Wilson; J Burn; P Scambler; J Goodship
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

7.  Genitourinary malformations in chromosome 22q11.2 deletion.

Authors:  Hsi-Yang Wu; Susan L Rusnack; Richard D Bellah; Natalie Plachter; Donna M McDonald-McGinn; Elaine H Zackai; Douglas A Canning
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

Review 8.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

9.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

10.  Epidemiology of hypospadias in Europe: a registry-based study.

Authors:  Jorieke E H Bergman; Maria Loane; Martine Vrijheid; Anna Pierini; Rien J M Nijman; Marie-Claude Addor; Ingeborg Barisic; Judit Béres; Paula Braz; Judith Budd; Virginia Delaney; Miriam Gatt; Babak Khoshnood; Kari Klungsøyr; Carmen Martos; Carmel Mullaney; Vera Nelen; Amanda J Neville; Mary O'Mahony; Annette Queisser-Luft; Hanitra Randrianaivo; Anke Rissmann; Catherine Rounding; David Tucker; Diana Wellesley; Natalya Zymak-Zakutnia; Marian K Bakker; Hermien E K de Walle
Journal:  World J Urol       Date:  2015-02-25       Impact factor: 4.226

View more
  4 in total

Review 1.  Etiology and management of early pregnancy renal anhydramnios: Is there a place for serial amnioinfusions?

Authors:  Angie C Jelin; Katelynn G Sagaser; Katherine R Forster; Tochi Ibekwe; Mary E Norton; Eric B Jelin
Journal:  Prenat Diagn       Date:  2020-02-19       Impact factor: 3.050

Review 2.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

3.  Associated Anomalies and Complications of Multicystic Dysplastic Kidney.

Authors:  Matjaž Kopač; Robert Kordič
Journal:  Pediatr Rep       Date:  2022-09-01

4.  Candidate modifier genes for immune function in 22q11.2 deletion syndrome.

Authors:  Catherina T Pinnaro; Travis Henry; Heather J Major; Mrutyunjaya Parida; Lucy E DesJardin; John R Manak; Benjamin W Darbro
Journal:  Mol Genet Genomic Med       Date:  2019-12-12       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.